ICD-9 code Description 284.81 Red cell aplasia (acquired)(adult)(with thymoma) 284.89 Other specified aplastic anemias 284.11 Antineoplastic chemotherapy induced pancytopenia 284.12 Other drug induced pancytopenia 284.19 Other pancytopenia 284.2 Myelophthisis 996.85 Complications of transplanted bone marrow 963.1 Poisoning by antineoplastic and immunosuppressive drugs E933.1 Antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use V58.11 Encounter for antineoplastic chemotherapy V87.41 Personal history of antineoplastic chemotherapy V58.12 Encounter for antineoplastic immunotherapy V67.2 Follow-up examination following chemotherapy V67.6 Follow-up examination following combined treatment V66.2 Convalescence following chemotherapy 042 HIV infection 79.53 Human immunodeficiency virus type 2 [HIV-2] 795.71 Nonspecific serologic evidence of human immunodeficiency virus [HIV] V08 Asymptomatic human immunodeficiency virus [HIV] infection status 996.81 Complications of transplanted kidney 996.83 Complications of transplanted heart 996.84 Complications of transplanted lung 996.82 Complications of transplanted liver V42.0 Kidney replaced by transplant V42.1 Heart replaced by transplant V42.6 Lung replaced by transplant V42.7 Liver replaced by transplant V42.81 Bone marrow replaced by transplant V42.82 Peripheral stem cells replaced by transplant V42.83 pancreas replaced by transplant V42.84 Organ or tissue replaced by transplant, intestines V42.89 Other specified organ or tissue replaced by transplant 279.2 Combined immunity deficiency 279.00 Hypogammaglobulinemia, unspecified 279.01 Selective IgA immunodeficiency 279.02 Selective IgM immunodeficiency 279.03 Other selective immunoglobulin deficiencies 279.04 Congenital hypogammaglobulinemia 279.05 Immunodeficiency with increased IgM 279.06 Common variable immunodeficiency 279.09 Other deficiency of humoral immunity 279.10 Immunodeficiency with predominant T-cell defect, unspecified 279.11 Digeorge's syndrome 279.12 Wiskott-aldrich syndrome 279.13 Nezelof's syndrome 279.19 Other deficiency of cell-mediated immunity 279.3 Unspecified immunity deficiency 279.41 Autoimmune lymphoproliferative syndrome 279.49 Autoimmune disease, not elsewhere classified 279.50 Graft-versus-host disease, unspecified 279.51 Acute graft-versus-host disease 279.52 Chronic graft-vs-host disease 279.53 Acute on chronic graft-versus-host disease 279.8 Other specified disorders involving the immune mechanism 279.9 Unspecified disorder of immune mechanism 201.00 Hodgkin's paragranuloma, unspecified site, extranodal and solid organ sites 201.01 Hodgkin's paragranuloma, lymph nodes of head, face, and neck 201.02 Hodgkin's paragranuloma, intrathoracic lymph nodes 201.03 Hodgkin's paragranuloma, intra-abdominal lymph nodes 201.04 Hodgkin's paragranuloma, lymph nodes of axilla and upper limb 201.05 Hodgkin's paragranuloma, lymph nodes of inguinal region and lower limb 201.06 Hodgkin's paragranuloma, intrapelvic lymph nodes 201.07 Hodgkin's paragranuloma, spleen 201.08 Hodgkin's paragranuloma, lymph nodes of multiple sites 201.10 Hodgkin's granuloma, unspecified site, extranodal and solid organ sites 201.11 Hodgkins granuloma, lymph nodes of head, face, and neck 201.12 Hodgkins granuloma, intrathoracic lymph nodes 201.13 Hodgkins granuloma, intra-abdominal lymph nodes 201.14 Hodgkins granuloma, lymph nodes of axilla and upper limb 201.15 Hodgkins granuloma, lymph nodes of inguinal region and lower limb 201.16 Hodgkins granuloma, intrapelvic lymph nodes 201.17 Hodgkins granuloma, spleen 201.18 Hodgkins granuloma, lymph nodes of multiple sites 201.20 Hodgkin's sarcoma, unspecified site, extranodal and solid organ sites 201.21 Hodgkins sarcoma, lymph nodes of head, face, and neck 201.22 Hodgkins sarcoma, intrathoracic lymph nodes 201.23 Hodgkins sarcoma, intra-abdominal lymph nodes 201.24 Hodgkins sarcoma, lymph nodes of axilla and upper limb 201.25 Hodgkins sarcoma, lymph nodes of inguinal region and lower limb 201.26 Hodgkins sarcoma, intrapelvic lymph nodes 201.27 Hodgkins sarcoma, spleen 201.28 Hodgkins sarcoma, lymph nodes of multiple sites 201.40 Hodgkin's disease, lymphocytic-histiocytic predominance, unspecified site, extranodal and solid organ sites 201.41 Hodgkin's disease, lymphocytic-histiocytic predominance, lymph nodes of head, face, and neck 201.42 Hodgkin's disease, lymphocytic-histiocytic predominance, intrathoracic lymph nodes 201.43 Hodgkin's disease, lymphocytic-histiocytic predominance,intra-abdominal lymph nodes 201.44 Hodgkin's disease, lymphocytic-histiocytic predominance, lymph nodes of axilla and upper limb 201.45 Hodgkin's disease, lymphocytic-histiocytic predominance, lymph nodes of inguinal region and lower limb 201.46 Hodgkin's disease, lymphocytic-histiocytic predominance, intrapelvic lymph nodes 201.47 Hodgkin's disease, lymphocytic-histiocytic predominance, spleen 201.48 Hodgkin's disease, lymphocytic-histiocytic predominance, lymph nodes of multiple sites 201.50 Hodgkin's disease, nodular sclerosis, unspecified site, extranodal and solid organ sites 201.51 Hodgkin's disease, nodular sclerosis, lymph nodes of head, face, and neck 201.52 Hodgkin's disease, nodular sclerosis, intrathoracic lymph nodes 201.53 Hodgkin's disease, nodular sclerosis, intra-abdominal lymph nodes 201.54 Hodgkin's disease, nodular sclerosis, lymph nodes of axilla and upper limb 201.55 Hodgkin's disease, nodular sclerosis, lymph nodes of inguinal region and lower limb 201.56 Hodgkin's disease, nodular sclerosis, intrapelvic lymph nodes 201.57 Hodgkin's disease, nodular sclerosis, spleen 201.58 Hodgkin's disease, nodular sclerosis, lymph nodes of multiple sites 201.60 Hodgkin's disease, mixed cellularity, unspecified site, extranodal and solid organ sites 201.61 Hodgkin's disease, mixed cellularity, lymph nodes of head, face, and neck 201.62 Hodgkin's disease, mixed cellularity,intrathoracic lymph nodes 201.63 Hodgkin's disease, mixed cellularity, intra-abdominal lymph nodes 201.64 Hodgkin's disease, mixed cellularity, lymph nodes of axilla and upper limb 201.65 Hodgkin's disease, mixed cellularity, lymph nodes of inguinal region and lower limb 201.66 Hodgkin's disease, mixed cellularity, intrapelvic lymph nodes 201.67 Hodgkin's disease, mixed cellularity, spleen 201.68 Hodgkin's disease, mixed cellularity, lymph nodes of multiple sites 201.70 Hodgkin's disease, lymphocytic depletion, unspecified site, extranodal and solid organ sites 201.71 Hodgkin's disease, lymphocytic depletion, lymph nodes of head, face, and neck 201.72 Hodgkin's disease, lymphocytic depletion, intrathoracic lymph nodes 201.73 Hodgkin's disease, lymphocytic depletion, intra-abdominal lymph nodes 201.74 Hodgkin's disease, lymphocytic depletion, lymph nodes of axilla and upper limb 201.75 Hodgkin's disease, lymphocytic depletion, lymph nodes of inguinal region and lower limb 201.76 Hodgkin's disease, lymphocytic depletion, intrapelvic lymph nodes 201.77 Hodgkin's disease, lymphocytic depletion, spleen 201.78 Hodgkin's disease, lymphocytic depletion, lymph nodes of multiple sites 201.90 Hodgkin's disease, unspecified type, unspecified site, extranodal and solid organ sites 201.91 Hodgkin's disease, unspecified type, lymph nodes of head, face, and neck 201.92 Hodgkin's disease, unspecified type, intrathoracic lymph nodes 201.93 Hodgkin's disease, unspecified type, intra-abdominal lymph nodes 201.94 Hodgkin's disease, unspecified type, lymph nodes of axilla and upper limb 201.95 Hodgkin's disease, unspecified type, lymph nodes of inguinal region and lower limb 201.96 Hodgkin's disease, unspecified type, intrapelvic lymph nodes 201.97 Hodgkin's disease, unspecified type, spleen 201.98 Hodgkin's disease, unspecified type, lymph nodes of multiple sites 202.00 Nodular lymphoma, unspecified site, extranodal and solid organ sites 202.01 Nodular lymphoma, lymph nodes of head, face, and neck 202.02 Nodular lymphoma, intrathoracic lymph nodes 202.03 Nodular lymphoma, intra-abdominal lymph nodes 202.04 Nodular lymphoma , lymph nodes of axilla and upper limb 202.05 Nodular lymphoma, lymph nodes of inguinal region and lower limb 202.06 Nodular lymphoma, intrapelvic lymph nodes 202.07 Nodular lymphoma, spleen 202.08 Nodular lymphoma, lymph nodes of multiple sites 202.10 Mycosis fungoides, unspecified site, extranodal and solid organ sites 202.11 Mycosis fungoides, lymph nodes of head, face, and neck 202.12 Mycosis fungoides, intrathoracic lymph nodes 202.13 Mycosis fungoides, intra-abdominal lymph nodes 202.14 Mycosis fungoides, lymph nodes of axilla and upper limb 202.15 Mycosis fungoides, lymph nodes of inguinal region and lower limb 202.16 Mycosis fungoides, intrapelvic lymph nodes 202.17 Mycosis fungoides, spleen 202.18 Mycosis fungoides, lymph nodes of multiple sites 202.20 Sezary's disease, unspecified site, extranodal and solid organ sites 202.21 Sezary's disease, lymph nodes of head, face, and neck 202.22 Sezary's disease, intrathoracic lymph nodes 202.23 Sezary's disease, intra-abdominal lymph nodes 202.24 Sezary's disease, lymph nodes of axilla and upper limb 202.25 Sezary's disease, lymph nodes of inguinal region and lower limb 202.26 Sezary's disease, intrapelvic lymph nodes 202.27 Sezary's disease, spleen 202.28 Sezary's disease, lymph nodes of multiple sites 202.30 Malignant histiocytosis, unspecified site, extranodal and solid organ sites 202.31 Malignant histiocytosis, lymph nodes of head, face, and neck 202.32 Malignant histiocytosis, intrathoracic lymph nodes 202.33 Malignant histiocytosis, intra-abdominal lymph nodes 202.34 Malignant histiocytosis, lymph nodes of axilla and upper limb 202.35 Malignant histiocytosis, lymph nodes of inguinal region and lower limb 202.36 Malignant histiocytosis, intrapelvic lymph nodes 202.37 Malignant histiocytosis, spleen 202.38 Malignant histiocytosis, lymph nodes of multiple sites 202.40 Leukemic reticuloendotheliosis, unspecified site, extranodal and solid organ sites 202.41 Leukemic reticuloendotheliosis, lymph nodes of head, face, and neck 202.42 Leukemic reticuloendotheliosis, intrathoracic lymph nodes 202.43 Leukemic reticuloendotheliosis, intra-abdominal lymph nodes 202.44 Leukemic reticuloendotheliosis, lymph nodes of axilla and upper limb 202.45 Leukemic reticuloendotheliosis, lymph nodes of inguinal region and lower limb 202.46 Leukemic reticuloendotheliosis, intrapelvic lymph nodes 202.47 Leukemic reticuloendotheliosis, spleen 202.48 Leukemic reticuloendotheliosis, lymph nodes of multiple sites 202.50 Letterer-siwe disease, unspecified site, extranodal and solid organ sites 202.51 Letterer-siwe disease, lymph nodes of head, face, and neck 202.52 Letterer-siwe disease, intrathoracic lymph nodes 202.53 Letterer-siwe disease, intra-abdominal lymph nodes 202.54 Letterer-siwe disease, lymph nodes of axilla and upper limb 202.55 Letterer-siwe disease, lymph nodes of inguinal region and lower limb 202.56 Letterer-siwe disease, intrapelvic lymph nodes 202.57 Letterer-siwe disease,spleen 202.58 Letterer-siwe disease, lymph nodes of multiple sites 202.60 Malignant mast cell tumors, unspecified site, extranodal and solid organ sites 202.61 Malignant mast cell tumors, lymph nodes of head, face, and neck 202.62 Malignant mast cell tumors, intrathoracic lymph nodes 202.63 Malignant mast cell tumors, intra-abdominal lymph nodes 202.64 Malignant mast cell tumors, lymph nodes of axilla and upper limb 202.65 Malignant mast cell tumors, lymph nodes of inguinal region and lower limb 202.66 Malignant mast cell tumors, intrapelvic lymph nodes 202.67 Malignant mast cell tumors, spleen 202.68 Malignant mast cell tumors, lymph nodes of multiple sites 202.70 Peripheral T cell lymphoma, unspecified site, extranodal and solid organ sites 202.71 Peripheral T cell lymphoma, lymph nodes of head, face, and neck 202.72 Peripheral T cell lymphoma, intrathoracic lymph nodes 202.73 Peripheral T cell lymphoma, intra-abdominal lymph nodes 202.74 Peripheral T cell lymphoma, lymph nodes of axilla and upper limb 202.75 Peripheral T cell lymphoma, lymph nodes of inguinal region and lower limb 202.76 Peripheral T cell lymphoma, intrapelvic lymph nodes 202.77 Peripheral T cell lymphoma, spleen 202.78 Peripheral T cell lymphoma, lymph nodes of multiple sites 202.80 Other malignant lymphomas, unspecified site, extranodal and solid organ sites 202.81 Other malignant lymphomas, lymph nodes of head, face, and neck 202.82 Other malignant lymphomas, intrathoracic lymph nodes 202.83 Other malignant lymphomas, intra-abdominal lymph nodes 202.84 Other malignant lymphomas, lymph nodes of axilla and upper limb 202.85 Other malignant lymphomas, lymph nodes of inguinal region and lower limb 202.86 Other malignant lymphomas, intrapelvic lymph nodes 202.87 Other malignant lymphomas,spleen 202.88 Other malignant lymphomas, lymph nodes of multiple sites 202.90 Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue, unspecified site, extranodal and solid organ sites 202.91 Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue, lymph nodes of head, face, and neck 202.92 Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue, intrathoracic lymph nodes 202.93 Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue, intra-abdominal lymph nodes 202.94 Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue, lymph nodes of axilla and upper limb 202.95 Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue, lymph nodes of inguinal region and lower limb 202.96 Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue, intrapelvic lymph nodes 202.97 Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue,spleen 202.98 Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue, lymph nodes of multiple sites 273.0 Polyclonal hypergammaglobulinemia 273.1 Monoclonal paraproteinemia 273.2 Other paraproteinemias 273.3 Macroglobulinemia 273.4 Alpha-1-antitrypsin deficiency 273.8 Other disorders of plasma protein metabolism 273.9 Unspecified disorder of plasma protein metabolism 203.00 Multiple myeloma, without mention of having achieved remission 203.01 Multiple myeloma, in remission 203.02 Multiple myeloma, in relapse 203.10 Plasma cell leukemia, without mention of having achieved remission 203.11 Plasma cell leukemia, in remission 203.12 Plasma cell leukemia, in relapse 203.80 Other immunoproliferative neoplasms, without mention of having achieved remission 203.81 Other immunoproliferative neoplasms, in remission 203.82 Other immunoproliferative neoplasms, in relapse 204.00 Acute lymphoid leukemia, without mention of having achieved remission 204.01 Acute lymphoid leukemia, in remission 204.02 Acute lymphoid leukemia, in relapse 204.10 Chronic lymphoid leukemia, without mention of having achieved remission 204.11 Chronic lymphoid leukemia, in remission 204.12 Chronic lymphoid leukemia, in relapse 204.20 Subacute lymphoid leukemia, without mention of having achieved remission 204.21 Subacute lymphoid leukemia, in remission 204.22 Subacute lymphoid leukemia, in relapse 204.80 Other lymphoid leukemia, without mention of having achieved remission 204.81 Other lymphoid leukemia, in remission 204.82 Other lymphoid leukemia, in relapse 204.90 Unspecified lymphoid leukemia, without mention of having achieved remission 204.91 Unspecified lymphoid leukemia, in remission 204.92 Unspecified lymphoid leukemia, in relapse 205.00 Acute myeloid leukemia, without mention of having achieved remission 205.01 Acute myeloid leukemia, in remission 205.02 Acute myeloid leukemia, in relapse 205.10 Chronic myeloid leukemia, without mention of having achieved remission 205.11 Chronic myeloid leukemia, in remsion 205.12 Chronic myeloid leukemia, in relapse 205.20 Subacute myeloid leukemia, without mention of having achieved remission 205.21 Subacute myeloid leukemia, in remission 205.22 Subacute myeloid leukemia, in relapse 205.30 Myeloid sarcoma, without mention of having achieved remission 205.31 Myeloid sarcoma, in remission 205.32 Myeloid sarcoma, in relapse 205.80 Other myeloid leukemia, without mention of having achieved remission 205.81 Other myeloid leukemia, in remsion 205.82 Other myeloid leukemia, in relapse 205.90 Unspecified myeloid leukemia, without mention of having achieved remission 205.91 Unspecified myeloid leukemia, in remission 205.92 Unspecified myeloid leukemia, in relapse 206.00 Acute monocytic leukemia, without mention of having achieved remission 206.01 Acute monocytic leukemia,in remission 206.02 Acute monocytic leukemia, in relapse 206.10 Chronic monocytic leukemia, without mention of having achieved remission 206.11 Chronic monocytic leukemia, in remission 206.12 Chronic monocytic leukemia, in relapse 206.20 Subacute monocytic leukemia, without mention of having achieved remission 206.21 Subacute monocytic leukemia, in remission 206.22 Subacute monocytic leukemia, in relapse 206.80 Other monocytic leukemia, without mention of having achieved remission 206.81 Other monocytic leukemia, in remission 206.82 Other monocytic leukemia, in relapse 206.90 Unspecified monocytic leukemia, without mention of having achieved remission 206.91 Unspecified monocytic leukemia, in remission 206.92 Unspecified monocytic leukemia, in relapse 207.00 Acute erythremia and erythroleukemia, without mention of having achieved remission 207.01 Acute erythremia and erythroleukemia, in remission 207.02 Acute erythremia and erythroleukemia, in relapse 207.10 Chronic erythremia, without mention of having achieved remission 207.11 Chronic erythremia, in remission 207.12 Chronic erythremia, in relapse 207.20 Megakaryocytic leukemia, without mention of having achieved remission 207.21 Megakaryocytic leukemia, in remission 207.22 Megakaryocytic leukemia, in relapse 207.80 Other specified leukemia, without mention of having achieved remission 207.81 Other specified leukemia, in remission 207.82 Other specified leukemia, in relapse 208.00 Acute leukemia of unspecified cell type, without mention of having achieved remission 208.01 Acute leukemia of unspecified cell type, in remission 208.02 Acute leukemia of unspecified cell type, in relapse 208.10 Chronic leukemia of unspecified cell type, without mention of having achieved remission 208.11 Chronic leukemia of unspecified cell type, in remission 208.12 Chronic leukemia of unspecified cell type, in relapse 208.20 Subacute leukemia of unspecified cell type, without mention of having achieved remission 208.21 Subacute leukemia of unspecified cell type, in remission 208.22 Subacute leukemia of unspecified cell type, in relapse 208.80 Other leukemia of unspecified cell type, without mention of having achieved remission 208.81 Other leukemia of unspecified cell type, in remission 208.82 Other leukemia of unspecified cell type, in relapse 208.90 Unspecified leukemia, without mention of having achieved remission 208.91 Unspecified leukemia, in remission 208.92 Unspecified leukemia, in relapse 238.71 Essential thrombocythemia 238.72 Low grade myelodysplastic syndrome lesions 238.73 High grade myelodysplastic syndrome lesions 238.74 Myelodysplastic syndrome with 5q deletion 238.75 Myelodysplastic syndrome, unspecified 238.76 Myelofibrosis with myeloid metaplasia 238.77 Post-transplant lymphoproliferative disorder (PTLD) 238.79 Other lymphatic and hematopoietic tissues 238.5 Neoplasm of uncertain behavior of histiocytic and mast cells 238.76 Myelofibrosis with myeloid metaplasia 289.89 Other specified diseases of blood and blood-forming organs V10.60 Personal history of leukemia, unspecified V10.61 Personal history of lymphoid leukemia V10.62 Personal history of myeloid leukemia V10.63 Personal history of monocytic leukemia V10.69 Personal history of other leukemia V10.71 Personal history of lymphosarcoma and reticulosarcoma V10.72 Personal history of hodgkin's disease V10.79 Personal history of other lymphatic and hematopoietic neoplasms